Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1996
11/13/1996EP0741565A1 Process for producing s(+)-ibuprofen particles
11/13/1996EP0741563A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
11/13/1996EP0741560A1 Process for solubilizing difficultly soluble pharmaceutical actives
11/13/1996EP0610178B1 Therapeutical composition and process for its preparation
11/13/1996EP0607156B1 Process for producing preserved medicaments containing human proteins for the purposes of infusion or injection
11/13/1996CN1135720A Biodegradable medicinal polymer assembly with supermolecular structure
11/13/1996CN1135719A Estramustine formulations with improved pharmaceutical properties
11/13/1996CN1135715A Novel composition
11/12/1996US5574142 Drug delivery to target cells, antisense oligodeoxynucleotides
11/12/1996US5574067 Method of treating wrinkles using gluconic acid or gluconolactone
11/12/1996US5574052 Agonist-antagonist combination to reduce the use of nicotine and other drugs
11/12/1996US5574045 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
11/12/1996US5574018 Conjugates of vitamin B12 and proteins
11/12/1996US5574006 Nasally administrable peptide compositions on hydroxyapatite carriers
11/12/1996US5573920 Antibodies, and methods for their use
11/12/1996US5573786 Preparation for skin and mucous membrane
11/12/1996US5573783 Redispersible nanoparticulate film matrices with protective overcoats
11/12/1996US5573781 Injectable fatty acid ester and cytostatic agent
11/12/1996US5573780 Stable solid formulation of enalapril salt and process for preparation thereof
11/12/1996US5573779 Drug delivery
11/12/1996US5573773 Photodynamic therapy of secondary cataract, antitumor
11/12/1996US5573757 Viscoelastic compositions containing concentrated fluorinated compounds their method of preparation and their uses
11/12/1996US5573668 Hydrophilic microporous membrane for drug delivery devices and method for preparing same
11/12/1996CA2053711C Compositions useful in inhibiting generation, maturation, motility and viability of sperm with minerals in biovailable form
11/12/1996CA2017507C Adjuvant formulation comprising a submicron oil droplet emulsion
11/12/1996CA1338702C High drug:lipid formulations of liposomal- antineoplastic agents
11/12/1996CA1338701C Low toxicity drug-lipid systems
11/12/1996CA1338699C Modified tpa-containing injection composition
11/12/1996CA1338698C Process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
11/07/1996WO1996034881A1 Peptide compositions with growth factor-like activity
11/07/1996WO1996034876A1 Nucleic acid ligand complexes
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996WO1996034630A1 Conjugates of folate and anti-effector cell antibodies
11/07/1996WO1996034629A1 Method and composition for prevention of posterior capsule opacification
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996034611A1 Methods to inhibit late radiation-induced skin damage
11/07/1996WO1996034610A1 Methods to inhibit acute radiation-induced skin damage
11/07/1996WO1996034606A1 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
11/07/1996WO1996034605A1 Composition comprising amoxycillin and clavulanic acid
11/07/1996WO1996034599A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
11/07/1996CA2220180A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2216377A1 Methods to inhibit acute radiation-induced skin damage
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0740934A1 Controlled release pharmaceutical compositions and method for preparing them
11/06/1996EP0740708A1 Design of drugs involving receptor-ligand-dna interactions
11/06/1996EP0740650A1 Codrugs as a method of controlled drug delivery
11/06/1996EP0740550A1 Use of mometasone furoate for treating airway passage and lung diseases
11/06/1996EP0740548A1 Drug targeting system, method for preparing same and its use
11/06/1996EP0740528A1 Gas microspheres for topical and subcutaneous application
11/06/1996EP0727996A4 Fenbendazole formulations
11/06/1996EP0706375A4 Proteinoid carriers
11/06/1996EP0689456A4 Cosmetic compositions
11/06/1996EP0413763B1 Method for the production of monoclonal antibodies utilizing a germfree animal
11/06/1996CN1135182A Immunoloigcal tolerance-inducting agent
11/06/1996CN1135181A Alteration of immune response using pan Dr-binding peptides
11/06/1996CA2175298A1 Recombinant obese (ob) proteins
11/05/1996US5571940 Method for making conjugate moieties capable of chelating paramagnetic metals and designed for coupling with a factor responsive to specific cellular marker sites
11/05/1996US5571844 Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
11/05/1996US5571841 Treating skin with mandelic acid for wrinkle reduction
11/05/1996US5571837 Method of treating wrinkles using saccharic acid or saccharolactone
11/05/1996US5571795 Glycosylated steroids coupled to a drug, transportation across biological membranes
11/05/1996US5571785 Antitumor agents; polymer-bound peptidyl anthracyclines
11/05/1996US5571782 Perfume and cyclodextrin complex for release of material when treated with water
11/05/1996US5571547 Process of sugarless hard coating and products obtained therefrom
11/05/1996US5571534 Drug formulations for parenteral use
11/05/1996US5571520 Molecular crystal redox device for pharmaceuticals
11/05/1996US5571510 Method for selective methionine starvation of malignant cells in mammals
11/05/1996US5571507 Methods of treating diabetes
11/05/1996US5571497 Pressurization of vessel containing liposome in liquid media followed by rapid depressurization
11/03/1996CA2175293A1 Pharmaceutical preparations having controlled release of active compound and processes for their preparation
10/1996
10/31/1996WO1996034109A1 Single-vial formulations of dna/lipid complexes
10/31/1996WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996033913A1 Novel uses of heptafluoropropane
10/31/1996WO1996033745A1 Formulations for lipophilic compounds
10/31/1996WO1996033744A2 Compositions in glassy phase, stabilised by a sugar
10/31/1996WO1996033743A1 Water soluble, powder form compositions and applications thereof
10/31/1996WO1996033742A1 Composition and method of enhancing electrotransport agent delivery
10/31/1996WO1996033725A1 Solvent detergent emulsions having antiviral activity
10/31/1996WO1996033722A1 External preparation containing emedastine
10/31/1996WO1996033706A1 Compositions and methods for inducing dermal analgesia
10/31/1996WO1996033698A1 Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell
10/31/1996WO1996033696A1 Novel collagen formulations
10/31/1996WO1996033695A2 Gel with increased oxygen content
10/31/1996WO1996033694A1 Pectic preparations used as medicament carriers
10/31/1996WO1996033678A1 Triacetin as a transdermal penetration enhancer
10/31/1996CA2219243A1 Novel uses of heptafluoropropane
10/31/1996CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof
10/31/1996CA2218037A1 Novel collagen formulations
10/31/1996CA2214029A1 Single-vial formulations of dna/lipid complexes
10/30/1996EP0739986A1 High trehalose content syrup
10/30/1996EP0739904A1 Bispecific reagents for aids therapy
10/30/1996EP0739634A2 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
10/30/1996EP0739628A2 A new composition containing selegiline
10/30/1996EP0739619A1 Foaming o/w emulsion based on non-ionic surfactants, a fatty phase and a cross-linked cationic or anionic polymer for topical use
10/30/1996EP0739415A1 Anti-hepatitis b poly- and oligonucleotides
10/30/1996EP0739358A1 Porous particle aggregate and method therefor
10/30/1996EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 1712